SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+1.82%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$179M
AUM Growth
+$179M
(-3.8%)
Cap. Flow
-$91.2M
Cap. Flow
% of AUM
-50.95%
Top 10 Holdings %
Top 10 Hldgs %
68.1%
Holding
152
New
35
Increased
13
Reduced
11
Closed
22
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$24.4M |
| 2 |
AGEN
Agenus
AGEN
|
$4.89M |
| 3 |
MannKind Corp
MNKD
|
$4.59M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.89M |
| 5 |
Sarepta Therapeutics
SRPT
|
$3.17M |
Top Sells
| 1 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$54.3M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$28.7M |
| 3 |
AbbVie
ABBV
|
$14.7M |
| 4 |
Zoetis
ZTS
|
$14.2M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$11.5M |
Sector Composition
| 1 | Healthcare | 90.22% |
| 2 | Financials | 0.57% |
| 3 | Technology | 0.56% |
| 4 | Consumer Staples | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vertex Pharmaceuticals
VRTX
$100B
| $25.5M | 1.66% | 336,955 +321,847 | +2,130% | +$24.4M |
|
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $24.7M | 1.6% | 522,041 +67,142 | +15% | +$3.17M |
|
|
AEGR
3
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $22.2M | 1.44% | 259,119 -334,743 | -56% | -$28.7M |
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $11.7M | 0.76% | 426,600 -377,655 | -47% | -$10.4M |
|
5
Gilead Sciences
GILD
$140B
| $9.73M | 0.63% | 154,871 -19,237 | -11% | -$1.21M |
|
|
ANTH
6
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $7.05M | 0.46% | 1,754,600 -13,504,474 | -89% | -$54.3M |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $6.76M | 0.44% | 112,849 +64,949 | +136% | +$3.89M |
|
|
8
MannKind Corp
MNKD
$1.41B
| $5.32M | 0.35% | 934,021 +806,014 | +630% | +$4.59M |
|
|
AGEN
9
Agenus
AGEN
$133M
| $4.89M | 0.32% | +1,763,663 | New | +$4.89M |
|
|
RPRX
10
DELISTED
Repros Therapeutics Inc.
RPRX
| $3.96M | 0.26% | 147,783 +85,693 | +138% | +$2.3M |
|
11
Achieve Life Sciences
ACHV
$152M
| $3.81M | 0.25% | 410,577 +13,847 | +3% | +$128K |
|
|
NWBO
12
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $3.28M | 0.21% | 978,359 +107,816 | +12% | +$361K |
|
|
EDAP
13
EDAP TMS
EDAP
$84.5M
| $3.19M | 0.21% | 1,259,500 +62,414 | +5% | +$158K |
|
14
Novavax
NVAX
$1.21B
| $2.77M | 0.18% | +875,000 | New | +$2.77M |
|
|
SZYM
15
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $2.14M | 0.14% | +198,350 | New | +$2.14M |
|
16
CASI Pharmaceuticals
CASI
$35.8M
| $2.06M | 0.13% | 1,178,956 +6,366 | +0.5% | +$11.1K |
|
17
Xoma
XOMA
$392M
| $2.04M | 0.13% | +455,672 | New | +$2.04M |
|
|
CEMP
18
DELISTED
Cempra, Inc.
CEMP
| $1.71M | 0.11% | 148,572 -1,428 | -1% | -$16.4K |
|
|
PCYC
19
DELISTED
PHARMACYCLICS INC
PCYC
| $1.71M | 0.11% | +12,350 | New | +$1.71M |
|
20
Eli Lilly
LLY
$657B
| $1.67M | 0.11% | 33,156 +14,934 | +82% | +$752K |
|
21
Tempest Therapeutics
TPST
$44M
| $1.61M | 0.1% | +162,000 | New | +$1.61M |
|
22
Savara
SVRA
$567M
| $1.6M | 0.1% | 3,639,571 -4,072,296 | -53% | -$1.79M |
|
23
Talphera
TLPH
$11.1M
| $1.6M | 0.1% | +148,070 | New | +$1.6M |
|
24
Madrigal Pharmaceuticals
MDGL
$9.76B
| $1.58M | 0.1% | 250,952 +34,684 | +16% | +$219K |
|
|
ACHN
25
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.46M | 0.1% | +484,879 | New | +$1.46M |
|